Torrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal involves Torrent acquiring KKR's 47.84% stake and launching an open offer, potentially leading to a Rs 20,734.61 crore buyout. This acquisition would bolster Torrent's branded generics portfolio and provide entry into the CDMO business.
For more details: Click here